Amrutanjan Health Care Limited (NSE:AMRUTANJAN)
India
· Delayed Price · Currency is INR 714.50
-8.00 (-1.11%)
Jun 6, 2025, 3:29 PM IST
Amrutanjan Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 4,518 | 4,212 | 3,796 | 4,058 | 3,328 | Upgrade
|
| Other Revenue | 176.79 | 1.41 | 1.23 | 1.06 | 1.69 | Upgrade
|
| Revenue | 4,695 | 4,214 | 3,798 | 4,059 | 3,330 | Upgrade
|
| Revenue Growth (YoY) | 11.42% | 10.96% | -6.45% | 21.90% | 27.23% | Upgrade
|
| Cost of Revenue | 2,232 | 2,170 | 1,874 | 1,838 | 1,432 | Upgrade
|
| Gross Profit | 2,463 | 2,043 | 1,924 | 2,221 | 1,899 | Upgrade
|
| Selling, General & Admin | 1,152 | 484.02 | 492.2 | 484.84 | 420.53 | Upgrade
|
| Other Operating Expenses | 551.95 | 1,026 | 960 | 879.76 | 647.2 | Upgrade
|
| Operating Expenses | 1,769 | 1,571 | 1,505 | 1,423 | 1,181 | Upgrade
|
| Operating Income | 693.53 | 472.47 | 418.55 | 798.41 | 717.93 | Upgrade
|
| Interest Expense | -2.19 | -1.57 | -0.77 | -4.85 | -5 | Upgrade
|
| Interest & Investment Income | - | 148.05 | 117.83 | 111.7 | 93.88 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.62 | 2.38 | 1.25 | 0.59 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.69 | 0.24 | 0.83 | 0.42 | Upgrade
|
| EBT Excluding Unusual Items | 691.34 | 620.26 | 538.23 | 907.34 | 807.82 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -1.26 | -2.05 | -1.57 | -3.67 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 1.57 | 0.27 | - | 0.89 | Upgrade
|
| Asset Writedown | - | -1.11 | - | - | - | Upgrade
|
| Pretax Income | 691.34 | 619.46 | 536.45 | 905.77 | 819.05 | Upgrade
|
| Income Tax Expense | 182.99 | 169.73 | 138.11 | 233.88 | 207.14 | Upgrade
|
| Earnings From Continuing Operations | 508.35 | 449.73 | 398.35 | 671.89 | 611.9 | Upgrade
|
| Net Income | 508.35 | 449.73 | 398.35 | 671.89 | 611.9 | Upgrade
|
| Net Income to Common | 508.35 | 449.73 | 398.35 | 671.89 | 611.9 | Upgrade
|
| Net Income Growth | 13.04% | 12.90% | -40.71% | 9.80% | 143.95% | Upgrade
|
| Shares Outstanding (Basic) | 29 | 29 | 29 | 29 | 29 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 29 | 29 | 29 | 29 | Upgrade
|
| Shares Change (YoY) | -0.36% | -0.71% | -0.03% | 0.00% | 0.02% | Upgrade
|
| EPS (Basic) | 17.58 | 15.50 | 13.65 | 23.00 | 20.94 | Upgrade
|
| EPS (Diluted) | 17.58 | 15.50 | 13.63 | 22.98 | 20.93 | Upgrade
|
| EPS Growth | 13.44% | 13.70% | -40.69% | 9.79% | 143.94% | Upgrade
|
| Free Cash Flow | 153.46 | 211.93 | 112.54 | 287.32 | 889.09 | Upgrade
|
| Free Cash Flow Per Share | 5.31 | 7.30 | 3.85 | 9.83 | 30.41 | Upgrade
|
| Dividend Per Share | - | 4.600 | 4.600 | 4.600 | 4.200 | Upgrade
|
| Dividend Growth | - | - | - | 9.52% | 281.82% | Upgrade
|
| Gross Margin | 52.46% | 48.49% | 50.65% | 54.72% | 57.01% | Upgrade
|
| Operating Margin | 14.77% | 11.21% | 11.02% | 19.67% | 21.56% | Upgrade
|
| Profit Margin | 10.83% | 10.67% | 10.49% | 16.55% | 18.38% | Upgrade
|
| Free Cash Flow Margin | 3.27% | 5.03% | 2.96% | 7.08% | 26.70% | Upgrade
|
| EBITDA | 758.79 | 520.33 | 458.66 | 830.49 | 747.3 | Upgrade
|
| EBITDA Margin | 16.16% | 12.35% | 12.08% | 20.46% | 22.44% | Upgrade
|
| D&A For EBITDA | 65.26 | 47.86 | 40.11 | 32.09 | 29.37 | Upgrade
|
| EBIT | 693.53 | 472.47 | 418.55 | 798.41 | 717.93 | Upgrade
|
| EBIT Margin | 14.77% | 11.21% | 11.02% | 19.67% | 21.56% | Upgrade
|
| Effective Tax Rate | 26.47% | 27.40% | 25.74% | 25.82% | 25.29% | Upgrade
|
| Revenue as Reported | 4,695 | 4,376 | 3,942 | 4,212 | 3,442 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.